We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$78.8B
AUM Growth
+$7.07B
Cap. Flow
+$2.22B
Cap. Flow %
2.81%
Top 10 Hldgs %
22%
Holding
3,838
New
237
Increased
1,800
Reduced
1,491
Closed
179

Sector Composition

Rank Sector Weight
1 Technology 11.07%
2 Financials 9.56%
3 Healthcare 8.56%
4 Industrials 6.35%
5 Communication Services 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBAY
3576
DELISTED
Cymabay Therapeutics
CBAY
$22K ﹤0.01%
11,059
-37,531
-77% -$141K
ATHX
3577
DELISTED
Athersys, Inc. Common Stock
ATHX
$22K ﹤0.01%
705
AVEO
3578
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$21K ﹤0.01%
3,330
-100
-3% -$736
MDR
3579
DELISTED
McDermott International
MDR
$21K ﹤0.01%
31,025
-6,679
-18% -$8.54K
PLM
3580
DELISTED
PolyMet Mining Corp.
PLM
$21K ﹤0.01%
8,387
TGB
3581
Trekor Metals
TGB
$3.21B
$20K ﹤0.01%
40,700
TOO
3582
DELISTED
Teekay Offshore Partners L.P.
TOO
$20K ﹤0.01%
13,180
-32,140
-71% -$49.4K
GILD icon
3583
CALL
Gilead Sciences
GILD
$165B
$19K ﹤0.01%
32,200
PDS
3584
Precision Drilling
PDS
$1.05B
$19K ﹤0.01%
682
-225
-25% -$5.16K
V icon
3585
CALL
Visa
V
$675B
$19K ﹤0.01%
21,000
-300
-1% -$54.1K
USB icon
3586
CALL
US Bancorp
USB
$100B
$18K ﹤0.01%
30,400
+2,600
+9% +$150K
BX icon
3587
CALL
Blackstone
BX
$113B
$17K ﹤0.01%
30,500
+5,500
+22% +$285K
PG icon
3588
CALL
Procter & Gamble
PG
$340B
$17K ﹤0.01%
+11,800
New +$1.44M
GPL
3589
DELISTED
Great Panther Mining Limited
GPL
$17K ﹤0.01%
3,250
+200
+7% +$1.05K
NEOS
3590
DELISTED
Neos Therapeutics, Inc
NEOS
$16K ﹤0.01%
10,500
GDX icon
3591
CALL
VanEck Gold Miners ETF
GDX
$27.6B
$15K ﹤0.01%
+18,400
New +$503K
IP icon
3592
CALL
International Paper
IP
$21.9B
$15K ﹤0.01%
58,397
+7,392
+14% +$310K
WPRT
3593
PUT
Westport Fuel Systems
WPRT
$35.7M
$15K ﹤0.01%
2,000
CBL
3594
DELISTED
CBL& Associates Properties, Inc.
CBL
$13K ﹤0.01%
12,626
+436
+4% +$570
CTXR icon
3595
Citius Pharmaceuticals
CTXR
$18.6M
$12K ﹤0.01%
480
VIVS
3596
VivoSim Labs
VIVS
$1.27M
$12K ﹤0.01%
146
-7
-5% -$655
NTRP
3597
DELISTED
Neurotrope, Inc. Common
NTRP
$12K ﹤0.01%
11,773
LCTX icon
3598
Lineage Cell Therapeutics
LCTX
$286M
$11K ﹤0.01%
12,278
+65
+0.5% +$54
TLGT
3599
DELISTED
Teligent, Inc
TLGT
$10K ﹤0.01%
2,250
-580
-20% -$3.6K
CTST
3600
DELISTED
CannTrust Holdings Inc. Common Share
CTST
$10K ﹤0.01%
+10,325
New +$10.3K

Similar funds

Raymond James & Associates's Q4 2019 Portfolio in Review

As of Q4 2019, Raymond James & Associates held 3,838 positions worth $78.8B, up 9.9% from $71.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Raymond James & Associates's Q4 2019 filing shows 237 new, 1,800 increased, 1,491 reduced and 179 closed positions. Its largest new stake was Direxion Daily S&P 500 Bear 1X ETF: 343,036 shares worth $8.38M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $325M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2019 buy was Direxion Daily S&P 500 Bear 1X ETF: 343,036 shares worth $8.38M.
  • Raymond James & Associates added most to Vanguard High Dividend Yield ETF in Q4 2019, an estimated $672M increase.
  • Raymond James & Associates's biggest Q4 2019 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $325M.
  • Raymond James & Associates fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $45.9M.
  • Raymond James & Associates's ten largest holdings make up 22% of its $78.8B portfolio in Q4 2019.
  • Raymond James & Associates opened 237 new positions and closed 179 in Q4 2019.
  • Raymond James & Associates's portfolio value rose 9.9% quarter-over-quarter to $78.8B.

Based on Raymond James & Associates's 13F filing for Q4 2019, filed 12 Feb 2020.